Search research articles
Contact Us
Filters
Showing results (401-410 of 453) with videos related to
Page
of 46
Sort By:
Neuro-Oncology
|
April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Neuro-Oncology Practice
|
July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative
Linda Dirven, Maartje E Vos, Tobias Walbert, et al.
JCI Insight
|
January 26, 2021
Developmental vascular malformations in EPAS1 gain-of-function syndrome
Jared S Rosenblum, Herui Wang, Pauline M Dmitriev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03
Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
JCO Precision Oncology
|
September 6, 2021
Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in Glioblastoma
Ying Pang, Guangyang Yu, Madison Butler, et al.
Neuro-Oncology
|
August 22, 2024
Distinct relapse pattern across molecular ependymoma types
Denise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology Advances
|
March 23, 2026
Discovery of genetic susceptibility variants in pediatric and adult ependymoma
Joshua D Strauss, Priya B Shetty, Spiridon Tsavachidis, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Journal of Neuro-Oncology
|
March 8, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
Amanda L King, Kayla N Roche, Heather E Leeper, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 453) with videos related to
Sort By:
Page
of 46
Neuro-Oncology
|
April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Neuro-Oncology Practice
|
July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative
Linda Dirven, Maartje E Vos, Tobias Walbert, et al.
JCI Insight
|
January 26, 2021
Developmental vascular malformations in EPAS1 gain-of-function syndrome
Jared S Rosenblum, Herui Wang, Pauline M Dmitriev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03
Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
JCO Precision Oncology
|
September 6, 2021
Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in Glioblastoma
Ying Pang, Guangyang Yu, Madison Butler, et al.
Neuro-Oncology
|
August 22, 2024
Distinct relapse pattern across molecular ependymoma types
Denise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology Advances
|
March 23, 2026
Discovery of genetic susceptibility variants in pediatric and adult ependymoma
Joshua D Strauss, Priya B Shetty, Spiridon Tsavachidis, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Journal of Neuro-Oncology
|
March 8, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
Amanda L King, Kayla N Roche, Heather E Leeper, et al.
Page
of 46